Table 1.
Region | SNP | f (Allele) | Group of samples† |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
CFAR |
MACS |
Coriell |
||||||||
White(n = 37) | Black (n = 65) | (n = 39) | NE (n = 10) | AfSS (n = 9) | Af-Am (n = 10) | CHN (n = 10) | MEX (n = 7) | |||
Exon-1 | -610G/A | f (G) | 0.69 | 0.77 | 0.74 | 0.75 | 0.78 | 0.75 | 0.45 | 0.57 |
f (A) | 0.31 | 0.23 | 0.26 | 0.25 | 0.22 | 0.25 | 0.55 | 0.43 | ||
-390T/A | f (T) | 0.61 | 0.46 | 0.72 | 0.70 | 0.50 | 0.40 | 0.40 | 0.50 | |
f (A) | 0.39 | 0.54 | 0.28 | 0.30 | 0.50 | 0.60 | 0.60 | 0.50 | ||
-52G/A | f (G) | 0.61 | 0.47 | 0.72 | 0.70 | 0.50 | 0.40 | 0.40 | 0.50 | |
f (A) | 0.39 | 0.53 | 0.28 | 0.30 | 0.50 | 0.60 | 0.60 | 0.50 | ||
-44C/G | f (C) | 0.82 | 0.92 | 0.72 | 0.70 | 0.94 | 0.90 | 0.95 | 0.79 | |
f (G) | 0.18 | 0.08 | 0.28 | 0.30 | 0.06 | 0.10 | 0.05 | 0.21 | ||
-20G/A | f (G) | 0.58 | 0.65 | 0.54 | 0.60 | 0.61 | 0.70 | 0.65 | 0.71 | |
f (A) | 0.42 | 0.35 | 0.46 | 0.40 | 0.39 | 0.30 | 0.35 | 0.29 | ||
79T/A | f (T) | 0.81 | 0.88 | 0.74 | 0.70 | 0.89 | 0.90 | 0.95 | 0.79 | |
f (A) | 0.19 | 0.12 | 0.26 | 0.30 | 0.11 | 0.10 | 0.05 | 0.21 | ||
Exon-2 | 1654G>A | f (G) | 0.97 | 0.92 | 1.00 | 1.00 | 0.89 | 0.90 | 1.00 | 0.93 |
f (A) | 0.03 | 0.08 | 0 | 0 | 0.11 | 0.10 | 0 | 0.07 | ||
1754G/A | f (G) | 0.89 | 0.95 | 0.85 | 0.80 | 0.94 | 0.95 | 0.70 | 0.93 | |
f (A) | 0.11 | 0.05 | 0.15 | 0.20 | 0.06 | 0.05 | 0.30 | 0.07 | ||
1836A/G | f (A) | 0.95 | 0.85 | 0.97 | 0.95 | 0.72 | 0.80 | 0.95 | 0.93 | |
f (G) | 0.05 | 0.15 | 0.03 | 0.05 | 0.28 | 0.20 | 0.05 | 0.07 | ||
1873T/C | f (T) | 0.97 | 0.96 | 1.00 | 1.00 | 1.00 | 0.90 | 1.00 | 1.00 | |
f (C) | 0.03 | 0.04 | 0 | 0 | 0 | 0.10 | 0 | 0 |
NE = Northern European, AfS S = African sub- Sahara, Af-Am = African-American, CHN = Chinese, MEX = Mexican.
CFAR patients of white and black races were self-identified.
MACS patients were white, non-Hispanic.